Per- and polyfluoroalkyl substances (PFAS), widely known as "forever chemicals," are facing broad regulatory restrictions across the European Union under the REACH regulation. For disposable glove buyers and procurement professionals, the 2027-2028 PFAS restriction timeline creates both compliance urgency and supply chain transition challenges. This guide explains what PFAS are, how they enter glove manufacturing, what the EU restriction requires, and how to verify PFAS-free claims when sourcing nitrile rubber gloves and other disposable gloves.

What Are PFAS and Why the EU Restriction Matters

PFAS are a family of over 12,000 synthetic chemicals characterized by carbon-fluorine bonds, which are among the strongest in organic chemistry. This molecular stability makes PFAS extremely persistent in the environment, bioaccumulative in human tissue, and linked to adverse health effects including certain cancers, immune suppression, and endocrine disruption.

In disposable glove manufacturing, PFAS may be used in three primary ways: (1) mold-release agents that help gloves separate from ceramic formers during dipping, (2) surface treatments for oil and water repellency, and (3) fluoropolymer additives in polymer blends. While not all gloves contain PFAS, their presence in manufacturing chains is widespread enough that the EU has moved toward a comprehensive restriction.

Current PFAS Use in Disposable Gloves

Not all disposable gloves contain PFAS. The risk varies by material type and manufacturing process. The table below summarizes PFAS risk levels by glove type.

EU REACH PFAS Restriction Timeline (2025-2028)

The EU PFAS restriction is being advanced through the REACH Annex XV process, led by authorities from Germany, the Netherlands, Norway, Sweden, and Denmark. The restriction proposal was submitted in January 2023, and the European Chemicals Agency (ECHA) Committee for Risk Assessment (RAC) has been reviewing scope and derogations. Key milestones for glove buyers include:

How to Verify PFAS-Free Claims

Procurement teams should not rely on marketing claims alone. A credible PFAS-free declaration from a glove manufacturer should include the following elements:

• Laboratory test report from an ISO 17025-accredited lab using LC-MS/MS or GC-MS methods for targeted PFAS analysis
• List of targeted PFAS compounds including PFOA, PFOS, PFHxS, GenX, and other relevant substances, with detection limits
• Manufacturing process declaration confirming no PFAS-containing mold-release agents, surface treatments, or additives are used
• Supply chain documentation verifying that raw material suppliers also provide PFAS-free declarations
• Batch-level traceability allowing specific glove lots to be traced back to PFAS-free production runs

Cost and Supply Chain Implications

The transition to PFAS-free manufacturing will have measurable cost and supply implications. Buyers should prepare for:

• Short-term price increase of 3-8% as manufacturers invest in alternative mold-release agents, reformulate polymer blends, and conduct additional testing
• Supply tightening as non-compliant manufacturers exit the EU market, reducing available capacity
• Testing costs of approximately $200-500 per product line per test cycle, which may be passed through to buyers
• Documentation burden requiring updated TDS, safety data sheets, and compliance declarations for each SKU

However, these costs should be weighed against the risk of non-compliance: product seizures at EU customs, market access loss, contract penalties, and reputational damage in ESG-conscious procurement markets.

Transition Strategy for Glove Buyers

Procurement teams should adopt a phased transition strategy starting immediately:

1. Audit current portfolio - Identify which gloves in your current supply may contain PFAS and assess replacement urgency based on EU sales volume
2. Request PFAS-free declarations from all existing suppliers with supporting lab test data
3. Source alternative suppliers where current suppliers cannot provide PFAS-free verification
4. Update specifications to include PFAS-free requirements in all new procurement documents and contracts
5. Plan inventory transition to avoid stranded stock of non-compliant gloves after the restriction deadline

FAQ

Q: What are PFAS and why are they used in disposable gloves?
A: PFAS (per- and polyfluoroalkyl substances) are a group of synthetic chemicals used in some glove manufacturing for oil and water repellency, mold-release agents during production, and surface treatments. They provide stain resistance and improve manufacturing efficiency but persist in the environment indefinitely, earning the name 'forever chemicals.'

Q: When will the EU PFAS restriction take effect for gloves?
A: The EU is advancing a broad PFAS restriction under REACH Annex XV, expected to enter force in 2027-2028. For disposable gloves, the transition period may vary by application, but manufacturers and buyers should prepare for compliance verification by mid-2027. The restriction covers intentionally added PFAS as well as PFAS present as impurities above threshold limits.

Q: How can I verify that gloves are PFAS-free?
A: Request a PFAS-free declaration from the manufacturer with supporting test data from an accredited laboratory. Common analytical methods include LC-MS/MS for targeted PFAS analysis. The declaration should reference specific PFAS compounds tested (e.g., PFOA, PFOS, GenX) and confirm levels are below detection limits or regulatory thresholds.

Q: Are nitrile rubber gloves naturally PFAS-free?
A: Nitrile rubber (acrylonitrile butadiene rubber) as a raw material does not inherently contain PFAS. However, PFAS may be introduced during manufacturing through mold-release agents, surface treatments, or contaminated additives. Buyers should still request explicit PFAS-free declarations even for nitrile rubber gloves to ensure the entire production chain is PFAS-free.

Q: Will PFAS-free gloves cost more than traditional gloves?
A: In the short term, PFAS-free gloves may carry a 3-8% cost premium due to reformulation, alternative mold-release agents, and additional testing requirements. As more manufacturers transition and scale economies improve, this premium is expected to narrow. Buyers should factor in the cost of non-compliance, which can include product recalls, market access loss, and reputational damage.